China Resources Sanjiu (000999.SZ): Yiqi Qingfei Granules Included in National Reimbursement Drug List

Stock News12-08

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) announced that its product Yiqi Qingfei Granules has been included in the National Reimbursement Drug List (NRDL) for the first time through negotiation. The inclusion follows the notice issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security regarding the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List as well as the Innovative Drug List for Commercial Health Insurance. The drug is now part of the 2025 NRDL.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180420983?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180420983","market":"fut","top_or_hot":-1,"title":"China Resources Sanjiu (000999.SZ): Yiqi Qingfei Granules Included in National Reimbursement Drug List","media":"Stock News","content":"<p>China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) announced that its product Yiqi Qingfei Granules has been included in the National Reimbursement Drug List (NRDL) for the first time through negotiation. The inclusion follows the notice issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security regarding the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List as well as the Innovative Drug List for Commercial Health Insurance. The drug is now part of the 2025 NRDL.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Sanjiu (000999.SZ): Yiqi Qingfei Granules Included in National Reimbursement Drug List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Sanjiu (000999.SZ): Yiqi Qingfei Granules Included in National Reimbursement Drug List\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-08 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) announced that its product Yiqi Qingfei Granules has been included in the National Reimbursement Drug List (NRDL) for the first time through negotiation. The inclusion follows the notice issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security regarding the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List as well as the Innovative Drug List for Commercial Health Insurance. The drug is now part of the 2025 NRDL.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"000999","symbol_name":"华润三九","start_time":0,"source_url":"","article_id":"1180420983","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180420983","pubTimestamp":1765183820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) announced that its product Yiqi Qingfei Granules has been included in the National Reimbursement Drug List (NRDL) for the first...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"000999":"华润三九","BK0188":"融资融券","BK0012":"证金概念","BK0175":"白马股","BK0196":"行业龙头","BK0010":"央企","BK0060":"抗癌","BK0239":"医药制造","BK0028":"国家队","BK0185":"二线龙头","BK0183":"MSCI概念"},"translate_title":"华润三九（000999.SZ）：益气清肺颗粒纳入国家报销药品目录","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000999":1},"content_text":"China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ) announced that its product Yiqi Qingfei Granules has been included in the National Reimbursement Drug List (NRDL) for the first time through negotiation. The inclusion follows the notice issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security regarding the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List as well as the Innovative Drug List for Commercial Health Insurance. The drug is now part of the 2025 NRDL.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180420983","isCrawlerRequest":true}